Skip to main content
Top
Published in: European Spine Journal 8/2015

01-08-2015 | Original Article

Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases

Authors: Shuai Han, Ting Wang, Dongjie Jiang, Yang Yu, Yu Wang, Wangjun Yan, Wei Xu, Ming Cheng, Wang Zhou, Jianru Xiao

Published in: European Spine Journal | Issue 8/2015

Login to get access

Abstract

Purpose

The aim of this study was to provide some useful insights into the clinical and imaging presentations, treatment and prognostic factors in patients with neurological deficit caused by clear cell renal cell carcinoma (CCRCC) spinal metastases for the sake of designing individualized therapeutic plans for such patients.

Methods

A total of 30 patients with neurological deficit due to CCRCC spinal metastases who received surgery in our department were identified during an 8-year period from 2003 to 2012 and used for discussion of treatment options for CCRCC spinal metastases on the basis of literature review and our own experience.

Results

Univariate analysis showed that age (≤45 years/>45 years), visceral metastasis, Tomita score (3–5/6–8), Tokuhashi score (4–9/10–12) and radiotherapy were suggested as the potential prognostic factors. However, the multivariate Cox regression model showed that only Tokuhashi score was an independent prognostic factor.

Conclusions

Tokuhashi score 10 or more is a favorable prognostic factor of CCRCC spinal metastasis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Herrmann E, Bierer S, Wulfing C (2010) Update on systemic therapies of metastatic renal cell carcinoma. World J Urol 28(3):303–309PubMedCrossRef Herrmann E, Bierer S, Wulfing C (2010) Update on systemic therapies of metastatic renal cell carcinoma. World J Urol 28(3):303–309PubMedCrossRef
2.
go back to reference Sundaresan N, Scher H, DiGiacinto GV, Yagoda A, Whitmore W, Choi IS (1986) Surgical treatment of spinal cord compression in kidney cancer. J Clin Oncol 4(12):1851–1856PubMed Sundaresan N, Scher H, DiGiacinto GV, Yagoda A, Whitmore W, Choi IS (1986) Surgical treatment of spinal cord compression in kidney cancer. J Clin Oncol 4(12):1851–1856PubMed
3.
go back to reference Chen F, Fujinaga T, Shoji T, Miyahara R et al (2008) Pulmonary resection for metastasis from renal cell carcinoma. Interact Cardiovasc Thorac Surg 7(5):825–828PubMedCrossRef Chen F, Fujinaga T, Shoji T, Miyahara R et al (2008) Pulmonary resection for metastasis from renal cell carcinoma. Interact Cardiovasc Thorac Surg 7(5):825–828PubMedCrossRef
4.
go back to reference Staehler M, Haseke N, Zilinberg E, Stadler T et al (2010) Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention. Urol Oncol 28(2):139–144PubMedCrossRef Staehler M, Haseke N, Zilinberg E, Stadler T et al (2010) Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention. Urol Oncol 28(2):139–144PubMedCrossRef
5.
go back to reference Zhang D, Xu W, Liu T, Yin H et al (2013) Surgery and prognostic factors of patients with epidural spinal cord compression caused by hepatocellular carcinoma metastases: retrospective study of 36 patients in a single center. Spine (Phila Pa 1976) 38(17):E1090–1095CrossRef Zhang D, Xu W, Liu T, Yin H et al (2013) Surgery and prognostic factors of patients with epidural spinal cord compression caused by hepatocellular carcinoma metastases: retrospective study of 36 patients in a single center. Spine (Phila Pa 1976) 38(17):E1090–1095CrossRef
6.
go back to reference Jacobsen KD, Folleras G, Fossa SD (1994) Metastases from renal cell carcinoma to the humerus or the shoulder girdle. Br J Urol 73(2):124–128PubMedCrossRef Jacobsen KD, Folleras G, Fossa SD (1994) Metastases from renal cell carcinoma to the humerus or the shoulder girdle. Br J Urol 73(2):124–128PubMedCrossRef
7.
go back to reference Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17(8):2530–2540PubMed Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17(8):2530–2540PubMed
8.
go back to reference Smith EM, Kursh ED, Makley J, Resnick MI (1992) Treatment of osseous metastases secondary to renal cell carcinoma. J Urol 148(3):784–787PubMed Smith EM, Kursh ED, Makley J, Resnick MI (1992) Treatment of osseous metastases secondary to renal cell carcinoma. J Urol 148(3):784–787PubMed
9.
go back to reference Tatsui CE, Suki D, Rao G, Kim SS et al (2014) Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma. J Neurosurg Spine 20(1):108–116PubMedCrossRef Tatsui CE, Suki D, Rao G, Kim SS et al (2014) Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma. J Neurosurg Spine 20(1):108–116PubMedCrossRef
10.
go back to reference Ulmar B, Naumann U, Catalkaya S, Muche R et al (2007) Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer. Ann Surg Oncol 14(2):998–1004PubMedCrossRef Ulmar B, Naumann U, Catalkaya S, Muche R et al (2007) Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer. Ann Surg Oncol 14(2):998–1004PubMedCrossRef
11.
go back to reference Laufer I, Sciubba DM, Madera M, Bydon A et al (2012) Surgical management of metastatic spinal tumors. Cancer Control 19(2):122–128PubMed Laufer I, Sciubba DM, Madera M, Bydon A et al (2012) Surgical management of metastatic spinal tumors. Cancer Control 19(2):122–128PubMed
12.
go back to reference Meyer F, Griesinger F, Willborn K, Sambale R, Thome C (2011) Treatment strategies for the multidisciplinary management of spinal metastasis. Dtsch Med Wochenschr 136(38):1907–1912PubMedCrossRef Meyer F, Griesinger F, Willborn K, Sambale R, Thome C (2011) Treatment strategies for the multidisciplinary management of spinal metastasis. Dtsch Med Wochenschr 136(38):1907–1912PubMedCrossRef
13.
go back to reference Kim CH, Chung CK, Jahng TA, Kim HJ (2011) Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis. Spine J 11(11):1015–1023PubMedCrossRef Kim CH, Chung CK, Jahng TA, Kim HJ (2011) Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis. Spine J 11(11):1015–1023PubMedCrossRef
14.
go back to reference Moon KY, Chung CK, Jahng TA, Kim HJ, Kim CH (2011) Postoperative survival and ambulatory outcome in metastatic spinal tumors: prognostic factor analysis. J Korean Neurosurg Soc 50(3):216–223PubMedCentralPubMedCrossRef Moon KY, Chung CK, Jahng TA, Kim HJ, Kim CH (2011) Postoperative survival and ambulatory outcome in metastatic spinal tumors: prognostic factor analysis. J Korean Neurosurg Soc 50(3):216–223PubMedCentralPubMedCrossRef
15.
go back to reference Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 15(11):1110–1113CrossRef Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 15(11):1110–1113CrossRef
16.
go back to reference Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (2001) Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 26(3):298–306CrossRef Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (2001) Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 26(3):298–306CrossRef
17.
go back to reference Riegel T, Schilling T, Sitter H, Benes L et al (2002) Analysis of factors affecting the prognosis of vertebral metastases. Zentralbl Neurochir 63(1):2–6PubMedCrossRef Riegel T, Schilling T, Sitter H, Benes L et al (2002) Analysis of factors affecting the prognosis of vertebral metastases. Zentralbl Neurochir 63(1):2–6PubMedCrossRef
18.
go back to reference Ulmar B, Richter M, Cakir B, Muche R, Puhl W, Huch K (2005) The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine (Phila Pa 1976) 30(19):2222–2226CrossRef Ulmar B, Richter M, Cakir B, Muche R, Puhl W, Huch K (2005) The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine (Phila Pa 1976) 30(19):2222–2226CrossRef
19.
go back to reference Faul CM, Flickinger JC (1995) The use of radiation in the management of spinal metastases. J Neurooncol 23(2):149–161PubMedCrossRef Faul CM, Flickinger JC (1995) The use of radiation in the management of spinal metastases. J Neurooncol 23(2):149–161PubMedCrossRef
20.
go back to reference Halperin EC, Harisiadis L (1983) The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51(4):614–617PubMedCrossRef Halperin EC, Harisiadis L (1983) The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51(4):614–617PubMedCrossRef
21.
go back to reference Gerszten PC, Burton SA, Ozhasoglu C, Vogel WJ et al (2005) Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine 3(4):288–295PubMedCrossRef Gerszten PC, Burton SA, Ozhasoglu C, Vogel WJ et al (2005) Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine 3(4):288–295PubMedCrossRef
22.
go back to reference Nguyen QN, Shiu AS, Rhines LD, Wang H et al (2010) Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185–1192PubMedCrossRef Nguyen QN, Shiu AS, Rhines LD, Wang H et al (2010) Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185–1192PubMedCrossRef
23.
go back to reference Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES et al (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484–490PubMedCrossRef Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES et al (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484–490PubMedCrossRef
24.
go back to reference Klish DS, Grossman P, Allen PK, Rhines LD, Chang EL (2011) Irradiation of spinal metastases: should we continue to include one uninvolved vertebral body above and below in the radiation field. Int J Radiat Oncol Biol Phys 81(5):1495–1499PubMedCrossRef Klish DS, Grossman P, Allen PK, Rhines LD, Chang EL (2011) Irradiation of spinal metastases: should we continue to include one uninvolved vertebral body above and below in the radiation field. Int J Radiat Oncol Biol Phys 81(5):1495–1499PubMedCrossRef
26.
go back to reference Riccardi A, Grasso D, Danova M (2003) Bisphosphonates in oncology: physiopathologic bases and clinical activity. Tumori 89(3):223–236PubMed Riccardi A, Grasso D, Danova M (2003) Bisphosphonates in oncology: physiopathologic bases and clinical activity. Tumori 89(3):223–236PubMed
27.
go back to reference Veri A, D’Andrea MR, Bonginelli P, Gasparini G (2007) Clinical usefulness of bisphosphonates in oncology: treatment of bone metastases, antitumoral activity and effect on bone resorption markers. Int J Biol 22(1):24–33 Veri A, D’Andrea MR, Bonginelli P, Gasparini G (2007) Clinical usefulness of bisphosphonates in oncology: treatment of bone metastases, antitumoral activity and effect on bone resorption markers. Int J Biol 22(1):24–33
28.
go back to reference Bhatia S, Curti B, Ernstoff MS, Gordon M et al (2014) Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study. J Immunother Cancer 2:2PubMedCentralPubMedCrossRef Bhatia S, Curti B, Ernstoff MS, Gordon M et al (2014) Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study. J Immunother Cancer 2:2PubMedCentralPubMedCrossRef
29.
go back to reference Escudier B, Michaelson MD, Motzer RJ, Hutson TE et al (2014) Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial. Br J Cancer 110(12):2821–2828PubMedCentralPubMedCrossRef Escudier B, Michaelson MD, Motzer RJ, Hutson TE et al (2014) Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial. Br J Cancer 110(12):2821–2828PubMedCentralPubMedCrossRef
30.
go back to reference Giehl JP, Kluba T (1999) Metastatic spine disease in renal cell carcinoma—indication and results of surgery. Anticancer Res 19(2C):1619–1623PubMed Giehl JP, Kluba T (1999) Metastatic spine disease in renal cell carcinoma—indication and results of surgery. Anticancer Res 19(2C):1619–1623PubMed
31.
go back to reference Robial N, Charles YP, Bogorin I, Godet J et al (2012) Is preoperative embolization a prerequisite for spinal metastases surgical management. Orthop Traumatol Surg Res 98(5):536–542PubMedCrossRef Robial N, Charles YP, Bogorin I, Godet J et al (2012) Is preoperative embolization a prerequisite for spinal metastases surgical management. Orthop Traumatol Surg Res 98(5):536–542PubMedCrossRef
Metadata
Title
Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases
Authors
Shuai Han
Ting Wang
Dongjie Jiang
Yang Yu
Yu Wang
Wangjun Yan
Wei Xu
Ming Cheng
Wang Zhou
Jianru Xiao
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
European Spine Journal / Issue 8/2015
Print ISSN: 0940-6719
Electronic ISSN: 1432-0932
DOI
https://doi.org/10.1007/s00586-015-3912-3

Other articles of this Issue 8/2015

European Spine Journal 8/2015 Go to the issue